- Home
- LNTH vs TENB Comparison
LNTH vs TENB Comparison
Compare LNTH & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TENB
- Stock Information
- Founded
- LNTH 1956
- TENB 2002
- Country
- LNTH United States
- TENB United States
- Employees
- LNTH N/A
- TENB N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TENB Computer Software: Prepackaged Software
- Sector
- LNTH Health Care
- TENB Technology
- Exchange
- LNTH Nasdaq
- TENB Nasdaq
- Market Cap
- LNTH 3.8B
- TENB 3.5B
- IPO Year
- LNTH 2015
- TENB 2018
- Fundamental
- Price
- LNTH $51.19
- TENB $27.53
- Analyst Decision
- LNTH Buy
- TENB Buy
- Analyst Count
- LNTH 6
- TENB 18
- Target Price
- LNTH $74.50
- TENB $39.88
- AVG Volume (30 Days)
- LNTH 1.4M
- TENB 1.2M
- Earning Date
- LNTH 11-06-2025
- TENB 10-29-2025
- Dividend Yield
- LNTH N/A
- TENB N/A
- EPS Growth
- LNTH N/A
- TENB N/A
- EPS
- LNTH 2.39
- TENB N/A
- Revenue
- LNTH $1,525,933,000.00
- TENB $974,603,000.00
- Revenue This Year
- LNTH N/A
- TENB $12.22
- Revenue Next Year
- LNTH $1.98
- TENB $7.62
- P/E Ratio
- LNTH $21.34
- TENB N/A
- Revenue Growth
- LNTH 1.95
- TENB 11.05
- 52 Week Low
- LNTH $47.25
- TENB $27.01
- 52 Week High
- LNTH $111.29
- TENB $45.45
- Technical
- Relative Strength Index (RSI)
- LNTH 36.35
- TENB 34.30
- Support Level
- LNTH $54.76
- TENB $28.55
- Resistance Level
- LNTH $61.92
- TENB $29.36
- Average True Range (ATR)
- LNTH 2.36
- TENB 0.80
- MACD
- LNTH -0.44
- TENB -0.24
- Stochastic Oscillator
- LNTH 4.15
- TENB 14.13
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.